CDMO News
ViroCell Completes Oversubscribed Funding Round Led by First Light Asset Management
ViroCell Biologics has successfully completed an oversubscribed convertible note offering, aimed at driving the company’s growth in the cell and gene therapy (CGT) sector. The funding round was led by new investor First Light Asset Management LLC, with participation from
16 August 2024